Mark Kaye - Jun 2, 2025 Form 4 Insider Report for CONMED Corp (CNMD)

Role: Director
Signature: /s/ Thomas Fistek for Mark Kaye by Power of Attorney
Stock symbol: CNMD
Transactions as of: Jun 2, 2025
Transactions value $: $0
Form type: 4
Date filed: 6/4/2025, 05:41 PM
Previous filing: Apr 25, 2025
Next filing: Oct 3, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kaye Mark	Director	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO	/s/ Thomas Fistek for Mark Kaye by Power of Attorney	2025-06-04	0001748691

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CNMD	Options To Purchase Common Stock	Award	$0	+8.06K		$0.00	8.06K	Jun 2, 2025	Common Stock	8.06K	$55.38	Direct	F1
transaction	CNMD	RSUs (Restricted Stock Units)	Award	$0	+668		$0.00	668	Jun 2, 2025	Common Stock	668	$0.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period.
F2	Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.

Content

The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.